Heart Disease Warnings Included in Labeling for Diabetes Drug Avandia
Warning labels on the diabetes drug Avandia® (rosiglitazone maleate), marketed by GlaxoSmithKline (GSK), caution that the medication can cause or worsen heart disease and that those who have experienced heart failure cannot be started on the drug.